News
For older patients with cancer and T2D, GLP-1 RA use is associated with lower all-cause mortality than DPP4i use.
For older patients with cancer and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is ...
Precision cancer treatment on a larger scale is moving closer after researchers have developed an AI platform that can tailor protein components and arm the patient's immune cells to fight cancer.
A team used generative AI to enhance T cells’ ability to fight melanoma. The immunotherapy approach needs more testing before use in cancer patients.
1d
News-Medical.Net on MSNDifferent anti-PD-L1 antibodies show varied results in tumor growth inhibitionImmune checkpoint inhibitors (ICIs), a powerful form of immunotherapy, have revolutionized cancer treatment by unleashing the ...
A western New York veteran who lost her job at the Department of Veterans Affairs earlier this year in President Donald Trump ...
"These breakthroughs have been lifesaving — for me and so many others who rely on cancer therapy." writes one reader.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results